Hepato-gastroenterology · 2002
Gastric pH and amylase and safety for non-stented pancreaticogastrostomy.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Shyr Yi-Ming, Su Cheng-Hsi, Wu Chew-Wun, Lui Wing-Yiu
Аннотация
BACKGROUND/AIMS: The main purpose of this study was to try to provide the indirect evidence of protection against marginal ulceration by neutralizing the gastric acidity with alkaline pancreatic secretions following non-stented pancreaticogastrostomy after pylorus-preserving pancreaticoduodenectomy (PPPD-PG). Safety of the non-stented PPPD-PG was also evaluated and reviewed.
METHODOLOGY: Twenty-five patients with resectable periampullary lesions undergoing non-stented PPPD-PG were recruited for study. Gastric pH and amylase levels were measured on postoperative day 7. Morbidity, pancreatic leakage and mortality were also evaluated.
RESULTS: The median values of gastric pH and amylase following non-stented PPPD-PG group were both statistically higher than those of healthy control group (pH, 6.3 vs. 2.8; amylase, 26,300 vs. 21 IU/L). The overall complication rate was 24.0%. Gastric atonia was the most common complication, occurring in 4 (16%) patients. No pancreatic leakage or ulcer-related complication such as upper gastrointestinal bleeding or perforation occurred in patients after non-stented PPPD-PG. There was 1 (4.0%) death, which was secondary to cardiac arrhythmia, but not related to operation.
CONCLUSIONS: Non-stented PPPD-PG could increase gastric pH and amylase levels, which might provide protection against marginal ulceration. No pancreatic leakage, and low morbidity and mortality confirm that non-stented PPPD-PG could be a relatively safe and reliable alternative in the pancreatic reconstruction after pancreaticoduodenecomy.
METHODOLOGY: Twenty-five patients with resectable periampullary lesions undergoing non-stented PPPD-PG were recruited for study. Gastric pH and amylase levels were measured on postoperative day 7. Morbidity, pancreatic leakage and mortality were also evaluated.
RESULTS: The median values of gastric pH and amylase following non-stented PPPD-PG group were both statistically higher than those of healthy control group (pH, 6.3 vs. 2.8; amylase, 26,300 vs. 21 IU/L). The overall complication rate was 24.0%. Gastric atonia was the most common complication, occurring in 4 (16%) patients. No pancreatic leakage or ulcer-related complication such as upper gastrointestinal bleeding or perforation occurred in patients after non-stented PPPD-PG. There was 1 (4.0%) death, which was secondary to cardiac arrhythmia, but not related to operation.
CONCLUSIONS: Non-stented PPPD-PG could increase gastric pH and amylase levels, which might provide protection against marginal ulceration. No pancreatic leakage, and low morbidity and mortality confirm that non-stented PPPD-PG could be a relatively safe and reliable alternative in the pancreatic reconstruction after pancreaticoduodenecomy.